NCT05158881View on ClinicalTrials.gov

Near-infrared Spectroscopy in Cerebral Oxygenation Monitoring in Full Term Neonates

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 10, 2021

Primary Completion Date

June 2, 2021

Study Completion Date

June 30, 2021

Conditions
Cerebral Oxygenation in Full-term Neonates
Interventions
DEVICE

Near-infrared spectroscopy

Near-infrared spectroscopy (NIRS) offers the non-invasive continuous monitoring of cerebral oxygenation and perfusion. Cerebral regional oxygen (crSO2) measured via NIRS represents a mixed tissue saturation value, thus enabling information on the balance of cerebral oxygen delivery and oxygen consumption.

Trial Locations (1)

21131

Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital., Alexandria

All Listed Sponsors
lead

Marwa Mohamed Farag

OTHER

NCT05158881 - Near-infrared Spectroscopy in Cerebral Oxygenation Monitoring in Full Term Neonates | Biotech Hunter | Biotech Hunter